Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C

BACKGROUND: An estimated 60,000 British Columbians are chronically infected with the hepatitis C virus (HCV); 10% to 20% will develop cirrhosis after 20 years and 5% to 10% of these will develop hepatocellular carcinoma. Although treatment may prevent cirrhosis and liver cancer, and improve quality...

Full description

Saved in:
Bibliographic Details
Main Authors: Priscilla C Hsu, Jane A Buxton, Andrew W Tu, Warren D Hill, Amanda Yu, Mel Krajden
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2008/243607
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850220767659163648
author Priscilla C Hsu
Jane A Buxton
Andrew W Tu
Warren D Hill
Amanda Yu
Mel Krajden
author_facet Priscilla C Hsu
Jane A Buxton
Andrew W Tu
Warren D Hill
Amanda Yu
Mel Krajden
author_sort Priscilla C Hsu
collection DOAJ
description BACKGROUND: An estimated 60,000 British Columbians are chronically infected with the hepatitis C virus (HCV); 10% to 20% will develop cirrhosis after 20 years and 5% to 10% of these will develop hepatocellular carcinoma. Although treatment may prevent cirrhosis and liver cancer, and improve quality of life, availability is limited.
format Article
id doaj-art-758dac8a57cc41d4857a2342cb87ad7f
institution OA Journals
issn 0835-7900
language English
publishDate 2008-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-758dac8a57cc41d4857a2342cb87ad7f2025-08-20T02:06:57ZengWileyCanadian Journal of Gastroenterology0835-79002008-01-0122435936410.1155/2008/243607Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis CPriscilla C Hsu0Jane A Buxton1Andrew W Tu2Warren D Hill3Amanda Yu4Mel Krajden5British Columbia Centre for Disease Control, CanadaBritish Columbia Centre for Disease Control, CanadaBritish Columbia Centre for Disease Control, CanadaBritish Columbia Centre for Disease Control, CanadaBritish Columbia Centre for Disease Control, CanadaBritish Columbia Centre for Disease Control, CanadaBACKGROUND: An estimated 60,000 British Columbians are chronically infected with the hepatitis C virus (HCV); 10% to 20% will develop cirrhosis after 20 years and 5% to 10% of these will develop hepatocellular carcinoma. Although treatment may prevent cirrhosis and liver cancer, and improve quality of life, availability is limited.http://dx.doi.org/10.1155/2008/243607
spellingShingle Priscilla C Hsu
Jane A Buxton
Andrew W Tu
Warren D Hill
Amanda Yu
Mel Krajden
Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
Canadian Journal of Gastroenterology
title Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
title_full Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
title_fullStr Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
title_full_unstemmed Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
title_short Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
title_sort publicly funded pegylated interferon alpha treatment in british columbia disparities in treatment patterns for people with hepatitis c
url http://dx.doi.org/10.1155/2008/243607
work_keys_str_mv AT priscillachsu publiclyfundedpegylatedinterferonalphatreatmentinbritishcolumbiadisparitiesintreatmentpatternsforpeoplewithhepatitisc
AT janeabuxton publiclyfundedpegylatedinterferonalphatreatmentinbritishcolumbiadisparitiesintreatmentpatternsforpeoplewithhepatitisc
AT andrewwtu publiclyfundedpegylatedinterferonalphatreatmentinbritishcolumbiadisparitiesintreatmentpatternsforpeoplewithhepatitisc
AT warrendhill publiclyfundedpegylatedinterferonalphatreatmentinbritishcolumbiadisparitiesintreatmentpatternsforpeoplewithhepatitisc
AT amandayu publiclyfundedpegylatedinterferonalphatreatmentinbritishcolumbiadisparitiesintreatmentpatternsforpeoplewithhepatitisc
AT melkrajden publiclyfundedpegylatedinterferonalphatreatmentinbritishcolumbiadisparitiesintreatmentpatternsforpeoplewithhepatitisc